{
    "title": "Pfizer, Roche and Aspen face South African probe into cancer drug prices",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4599754/Pfizer-Roche-Aspen-face-South-Africa-probe-cancer-drug-prices.html",
    "date": "2017-06-13",
    "keywords": [
        "commission",
        "competition",
        "cancer",
        "company",
        "roche",
        "investigation",
        "pfizer",
        "sector",
        "drug",
        "notification",
        "comment",
        "aspen",
        "dludla",
        "pretoria",
        "june",
        "watchdog",
        "agencys",
        "chief",
        "head",
        "agency",
        "pharmacare",
        "africas",
        "maker",
        "suspicion",
        "reason",
        "pricing",
        "market",
        "book",
        "bonakele",
        "news",
        "conference",
        "healthcare",
        "priority",
        "enforcement",
        "impact",
        "conduct",
        "tribunal",
        "adjudication",
        "lung",
        "treatment",
        "crizotinib",
        "breast",
        "herceptin",
        "herclon",
        "durban",
        "leukeran",
        "alkeran",
        "myleran",
        "email",
        "case",
        "information",
        "telephone",
        "wrongdoing",
        "margin",
        "health",
        "department",
        "engagement",
        "statement",
        "reporting",
        "paul",
        "arnold",
        "writing",
        "tiisetso",
        "motsoeneng",
        "editing",
        "mark",
        "potter",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}